Medicine by Prof. Tariq Waseem

Medicine by Prof. Tariq Waseem Head Department of Medicine Saleem Memorial Hospital.Formerly Professor of Medicine at KEMU & AIMC.

Physicians Forum: Today's CaseA 60-year-old lady who is known Diabetic and hypertensive on Oral Hypoglycemic Agents and ...
25/10/2025

Physicians Forum: Today's Case

A 60-year-old lady who is known Diabetic and hypertensive on Oral Hypoglycemic Agents and ARBs noticed gradually increasing abdominal distension for past 6 months and low grade fever. She visited various health care facilities and worked up for Ascites. Two months ago peritoneal aspiration confirmed Exudative Ascites with high lymphocytes. She was started on antituberculous treatment (Rifa-4) which she took for 3-4 weeks but her distension increased. 1 week before admission to hospital she developed watery diarrhea, decreased urine output and fever 100 F. She was started on some antibiotics in addition to ATT. She then developed the rash mainly over calves and feet but also on forearms and trunk(See the attached picture). She also complained of severe abdominal Pain.
On examination she had tense ascites with tender abdomen, bowel sounds were audible. There were no stigmata of CLD and rest of the examination was unremarkable.
Lab Work: Creatinine 3.2, Urine C/ E microscopic haematuria, Normal Coagulation profile. Normal CBC.
A Diagnosis of drug induced Vs Malignancy related vasculitis was considered.
CA 125 was elevated (550).
Therapeutic Peritoneal Aspiration was performed and repeat fluid analysis came "POSITIVE FOR MALIGNANT CELLS". A CT scan chest and abdomen showed widespread nodules in Perotonium, omentum and around adenexae, which were otherwise reported Normal.
ATT was stopped, she was started on Prednisolone in tapering dose. Her rash improved, Creatinine returned to normal levels. Today the case was discussed in physician Forum which is a MDT platform based at Saleem Memorial Hospital.
A final diagnosis of Ovarian Malignancy/ Peritoneal Carcinomatosis, Henoch Schonlein purpura secondary to ATT/ Malignancy, AKI precipitated by diarrhea.

Oncologist recommended: CT guided peritoneal/ Omental biopsy for histopathology.

Suggestions comments are welcomed.

Today’s Case at Physician Forum:A 37-year-old female diagnosed Rheumatoid Arthritis for 5-6 years. She has been on diffe...
11/10/2025

Today’s Case at Physician Forum:

A 37-year-old female diagnosed Rheumatoid Arthritis for 5-6 years. She has been on different DMARDs with little response and is on steroids. Recently, she started on salazodine but developed a papular skin rash. She was worked up for latent TB before starting on biological. IGRA came positive, and she was started on ATT, which she took for 3 weeks.
She has chronic microcytic, hypochromic anamia unresponsive to IV iron for 5-6 years, and Hb has always been 6-7 G/dl.
She presents with high-grade fever, persistent vomiting, and abdominal pain.
Blood and urine cultures had no growth.
Extensive workup for active TB, including CXR, HRCT chest, and Sputum, were negative.
Procalcitonin and TLC were raised.
She was started on Solumedrol 500 mg IV OD, IV antibiotics, anti emetics, and PPI.
Anti DS DNA turned out to be positive.
HbsAg and Anti HCV were negative.
Autoimmune hepatitis screening negative.

Points discussed.
1. Which tests are more specific and sensitive to diagnose latent TB in low - and middle income countries like Pakistan where BCG vaccination is a routine.
2. What ATT regime and for how long to treat latent TB.
3. She is planning to start family and have a baby. What are treatment options?
4. Does she have RA, SLE, or MCTD.
Discussion was joined on Zoom by eminent Rheumatologists and Pulmonologist, oncologist, and internist, in addition to scores of PGRs.

Case was presented by Dr. Najam PGY4 and moderated by @⁨Hunza Malik SR SMTH⁩.

Celebrating World Heart Day 29th September 2025.Public Awareness Seminar on "Gender Differences in Cardiovascular Diseas...
27/09/2025

Celebrating World Heart Day 29th September 2025.
Public Awareness Seminar on
"Gender Differences in Cardiovascular Disease Risks and Symptoms."

Transdermal hormone replacement therapy (HRT) in women with type 2 diabetes (T2D) was associated with a lower risk for i...
27/09/2025

Transdermal hormone replacement therapy (HRT) in women with type 2 diabetes (T2D) was associated with a lower risk for ischemic heart disease, whereas oral HRT was linked to increased cardiovascular issues, including a twofold higher risk for pulmonary embolism and a 21% greater risk for ischemic heart disease.

In women with type 2 diabetes, transdermal HRT was associated with reduced ischemic heart disease risk and oral HRT was linked to higher cardiovascular risks, including for pulmonary embolism and ischemic heart disease.

22/09/2025
Presented at the EASD Annual Meeting 2025:In the ATTAIN-1 phase 3 trial, the use of orforglipron, an oral GLP-1 receptor...
16/09/2025

Presented at the EASD Annual Meeting 2025:

In the ATTAIN-1 phase 3 trial, the use of orforglipron, an oral GLP-1 receptor agonist, led to significant mean body-weight reductions in patients with obesity, as compared with placebo. Full trial results:

Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, doubl...

08/09/2025

Baxdrostat: A 'Game Changer' for Hypertension?

A new class of antihypertensive agent that blocks the production of aldosterone — a key hormone believed to drive increased blood pressure — has shown impressive results in one of the first pivotal phase 3 trials in patients with resistant or uncontrolled hypertension.

Use of baxdrostat was associated with a reduction in office-measured systolic blood pressure of around 9 mm Hg at 12 weeks and reductions in 24-hour ambulatory systolic blood pressure of around 15 mm Hg in the BaxHTN trial.

The development of baxdrostat and related drugs is “a triumph of scientific discovery,” following the finding that disturbed aldosterone production to be a key driver of hard-to-control hypertension.

Sources: Medscape/ NEJM/ ESC 2025.

Join us at Saleem Memorial Trust Hospital Lahore for a comprehensive review on " The Role of Oral Hypoglycemic Agents (O...
07/09/2025

Join us at Saleem Memorial Trust Hospital Lahore for a comprehensive review on " The Role of Oral Hypoglycemic Agents (OHA) in the Management of Type 2 Diabetes Mellitus." The session will be live on Zoom as well.
Registration is mandatory to earn an e-ceriticate for participation.

To Register click at

https://docs.google.com/forms/d/1fKEQ8vcGfhCWRZ8cz6N_Ay1thLHUCdec9I-D55bu0mk/edit

Zoom Link

https://us06web.zoom.us/j/82319618715?pwd=X9aPIepUeV0sSoiuIbXgaysIFi2LcH.1
Meeting ID: 823 1961 8715
Passcode: 646122

04/09/2025

بلڈ پریشر کا علاج کب اور کیسے؟ناظرین بلڈ پریشر اور آپ کے سلسلہ کی اس نشست میں ہم اس کے علاج میں استعمال ہونے والی دواؤں کے بارے میں کچھ جانیں گے کہ وہ کس طرح...

Address

Lahore
54000

Website

Alerts

Be the first to know and let us send you an email when Medicine by Prof. Tariq Waseem posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram